Initially there was no specific way to reverse the the the the the the the the the the the like um so uh like so you know like you you you you you you you you you you you know uh anticoagulant effect of dabigatran in the event of a a a a a a a a a a a major okay okay so um uh you know you you you you you you you you you you you know okay uh you know bleeding event, unlike for for for for for for for for for for for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.